| About Us | Addiction Treatment | Special Patient Groups |
In the News | Resources and Events |
Frequently Asked Questions |
Ethan Nadelmann, Executive Director of Drug Policy Alliance, gives an impassioned presentation to the NAACP that addresses the harms of the US drug war. He speaks from the perspective of a human rights advocate. "... I hope and pray that as reforms come up...we all recognize a moral obligation to reduce the role of criminalization in drug policy. We need to move to a place where our drug policy is grounded in science, compassion, health and human rights.
July 24, 2009: Audio:MP3 (8.58 minutes)
An Interview with Jonathan Cohen, Director of Law and Health Initiative, OSI
July 6, 2009: Audio:MP3 (16.23 minutes)
An Interview with Herman Joseph, and a look back on the last 40 years of Methadone Advocacy.
January 26, 2008: Audio:MP3 (14.08 minutes)
Dr. Campopiano's patient shares her story of addiction and her quest to find treatment and get her life back with a group of family practice medical residents in Pittsburgh.
May 6, 2008: Audio:MP3 (18.20 minutes)
Dorothea Kleiber recounts her son's struggle with heroin and the lack of addiction treatment and understanding at that time. Dorothea was an instrumental part in the creation of a successful advocacy movememt in Germany which forced positive change.
November 8 , 2007: Audio:MP3 (10.44 minutes)
Dr. Robert Newman and Dr. Robert Hämmig, President of the Swiss Society of Addiction Medicine, met up in Ljubljana, Slovenia at the First World Conference on Medication Assisted Treatment of Opiate Addiction. There they discussed how Dr. Hämmig began in the field and how Switzerland arrived at its current treatment situation.
August 2, 2007: Audio:MP3 (12.42 minutes)
Nabarun Dasgupta, a graduate student at the Univ. of North Carolina School of Public Health and member of the board of the NC Harm Reduction Coalition, discusses the challenges and progress of harm reduction in the southern U.S.A..
July 12, 2007: Audio:MP3 (15.04 minutes)
Nadya Mikdashi of the Lebanese Harm Reduction Program, Skoun, speaks about the current conditions in Lebanon and the drug treatment options available to patients.
June 18, 2007: Audio:MP3 (16.47 minutes)
Dr. Andrew Byrne, from Sydney Australia talks candidly about his experience over the last 20 years treating patients suffering from heroin and opiate addiction.
April 19, 2007: Audio:MP3 (13.05 minutes)
Dr. Newman, Director of the International Center of Advancement of Addiction Treatment, discusses the current climate of methadone and the media. Including news related to Anna Nichole Smith, Methadone Overdose Deaths and Emergency Visits.
March 20, 2007: Audio:MP3 (19.16 minutes)
Dr. Newman, Director of the International Center of Advancement of Addiction Treatment, provides an overview of the challenges facing opiate addiction treatment to an audience in India. The podcast is accompanied by a PDF (presentation slides)
January 30, 2007: Audio:MP3 (9.07 minutes)
Sharon Stancliff, MD, Medical Director of the Harm Reduction Coalition in NYC, discusses the recent outbreak of fentanyl overdoses that caused more than 600 deaths across the US in 2006. On overview of what fentanyl is, where the supply is coming from, what can and should be done to assist in prevention of future overdoses are all issues that are discussed during the podcast.
January 9, 2007: Audio:MP3 (9.17 minutes)
David Marsh, MD, Medical Director of INSITE, presents the first three years of experience at the ground breaking program.
December 12, 2006: Audio:MP3 (13.28 minutes)
Dr. Azarakhsh Mokri discusses opiate dependence and the impact of Islamic beliefs on treating addiction. The interview provides insight into Iran’s history of treating addiction and the cultural and political forces at work in Iran and around the globe.
November 16, 2006: Audio:MP3 (14.59 minutes)
Alex Wodak, MD, world renowned leader in drug treatment, leads an interesting, exploratory discussion on Methadone as a failed market. He questions whether heroin consumption follows other marketing models (e.g alcohol), with disproportionate consumption - do 20% of heroin users consume 70% of heroin? And if so, should treatment be aimed predominantly at these individuals to combat crime and new converts. He poses the question as to how many people should receive methadone, buprenorphine and other treatments and even if those numbers were known, could demand be met? In the end, he concludes Methadone is a failed market worldwide because demand outstrips supply due outside influences (politics, cost, stigma, etc).
October 26, 2006: Audio:MP3 (19.20 minutes)
Dr. Robert Newman and Peter Vanderkloot discuss the various types, process, reliability and purpose of drug testing and screening. The discussion covers general issues from employment testing to more specific drug screening that occurs within the scope of addiction treatment.
October 10, 2006: Audio:MP3 (16.35 minutes)
Pittsburg family physician, Dr. Melinda Campopiano, is responsible for treating the health issues of her community from the common cold to diabetes to weight issues and now this includes addiction. She talks about her experiences treating addiction with Buprenorphine.
September 14, 2006: Audio:MP3 (19.15 minutes)
Dr. Melinda Campopiano discusses treating her first patient with Buprenorphine, and the positive effect of the treatment.
September 10, 2006: Audio:MP3 (5.55 minutes)
The BBC offers tribute to Dr. Dole. An interview with Robert G. Newman, MD, sheds light on the man who was a pioneer in the field of addiction treatment.
August 4, 2006: Audio:MP3 (4.32 minutes)
